Cargando…
Fucosylated α(1)-acid glycoprotein as a biomarker to predict prognosis following tumor immunotherapy of patients with lung cancer
Immunotherapy targeting immune checkpoint molecules has provided remarkable clinical benefits in cancer patients but no clinically relevant biomarker for predicting treatment outcomes exists. Recently, we demonstrated that glycan structures of serum α(1)-acid glycoprotein (AGP) changed dramatically...
Autores principales: | Yokobori, Takehiko, Yazawa, Shin, Asao, Takayuki, Nakazawa, Nobuhiro, Mogi, Akira, Sano, Rie, Kuwano, Hiroyuki, Kaira, Kyoichi, Shirabe, Ken |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6787216/ https://www.ncbi.nlm.nih.gov/pubmed/31601857 http://dx.doi.org/10.1038/s41598-019-51021-2 |
Ejemplares similares
-
Fucosylated Glycans in α1-Acid Glycoprotein for Monitoring Treatment Outcomes and Prognosis of Cancer Patients
por: Yazawa, Shin, et al.
Publicado: (2016) -
Development of a Novel System for Mass Spectrometric Analysis of Cancer-Associated Fucosylation in Plasma α
(1)-Acid Glycoprotein
por: Asao, Takayuki, et al.
Publicado: (2013) -
ASO Author Reflections: Genetic and Immunohistochemical Studies Investigating the Histogenesis of Neuroendocrine and Carcinomatous Components of Combined Neuroendocrine Carcinoma
por: Iijima, Misaki, et al.
Publicado: (2019) -
Carbonic anhydrase 9 expression is associated with poor prognosis, tumor proliferation, and radiosensitivity of thymic carcinomas
por: Ohtaki, Yoichi, et al.
Publicado: (2019) -
Skeletal muscle mass predicts the outcome of nivolumab treatment for non-small cell lung cancer
por: Tsukagoshi, Mariko, et al.
Publicado: (2020)